Drugs / Dapagliflozin/Metformin
last change Apr 2026 re-read 2 minutes ago

Dapagliflozin/Metformin

Developed for
polycystic ovary syndrome
Investigated by
Beni-Suef University

Trials 1 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT06405178 Mar 2026 polycystic ovary syndrome Beni-Suef University Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Dapagliflozin/Metformin ClinicalTrials.gov intervention name — accepted as the source's own label NCT06405178